To solve this problem, a randomized study investigating the association between LAPTM4B-35 expression and prognosis should be conducted to confirm whether LAPTM4B-35 could be used as a novel predictor of PCa prognosis. The gene discussed is LAPTM4B; the disease is posterior cortical atrophy.